Management and treatment of bronchial asthma in adults and children on the basis of new guidelines

Author:

Książkiewicz Anna1,Kwilosz Edyta1,Fornal Rafał2,Dworzańska Ewa3

Affiliation:

1. Zakład Pielęgniarstwa, Państwowa Wyższa Szkoła Zawodowa w Krośnie

2. Oddział Dziecięcy Wojewódzkiego Szpitala Podkarpackiego w Krośnie

3. Klinika Neurologii Dziecięcej, Uniwersytet Medyczny w Lublinie

Abstract

Bronchial asthma is the most common chronic disease in children and adults under 40 years of age. Characteristic symptoms include wheezing, shortness of breath, tightness of the chest and a cough varying in time and intensity. The disease usually begins in childhood and lasts a lifetime, with periods of exacerbation and remission. Asthma can occur at any age, but in approximately 80% of cases the first asthma attack occurs before the age of 5. Over the past several years, progress in the diagnosis and monitoring of patients with asthma has been made. In addition to the long-established objective assessment methods, such as functional tests, rapid asthma control questionnaires recommended for use in daily practice and noninvasive methods for assessing inflammation have been introduced. The availability of these methods and their degree of use in routine practice are variable. Taking careful history with the child and parents is very important. A detailed history is the first and primary step of asthma recognition. While in the case of adults, the observation period and available methods usually allow us to make reliable diagnosis of the disease, in younger children the diagnosis is associated with difficulties resulting from the inability to use some diagnostic tools. The paper discusses the currently available diagnostic methods and those used for monitoring the disease, especially the most current ones used in the youngest children. Medications used in asthma treatment have been characterized, including new therapeutic options, especially biological treatment. Particular attention was paid to the education of the patient and caregivers, which, apart from well-established treatment, determines good asthma control.

Publisher

Walter de Gruyter GmbH

Subject

Infectious Diseases,Microbiology (medical)

Reference75 articles.

1. Akdis C.A., Akdis M.: Mechanisms of allergen-specific immunotherapyand immune tolerance to allergens. World Allergy Organ.J., 2015; 8: 17

2. Anderson H.R., Bland J.M., Patel S., Peckham C.: The natural history ofasthma in childhood. J. Epidemiol. Community Health, 1986; 40: 121–129

3. Asamoah F., Kakourou A., Dhami S., Lau S., Agache I., MuraroA., Roberts G., Akdis C., Bonini M., Cavkaytar O., Flood B., IzuharaK., Jutel M., Kalayci Ö. i wsp.: Allergen immunotherapy for allergicasthma: A systematic overview of systematic reviews. Clin. Transl.Allergy, 2017; 7: 25

4. Baddar S., Jayakrishnan B., Al-Rawas O.A.: Asthma control: Importanceof compliance and inhaler technique assessments. J. Asthma,2014; 51: 429–434

5. Barnes P.J.: Theophylline. Am. J. Respir. Crit. Care Med., 2013;188: 901–906

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3